Click on a filter below to refine your search. Remove a filter to broaden your search.
Objectively assessed VMS (so-called hot flashes), including sleep VMS, are associated with significantly lower amyloid-β42/40.
A five-point higher brain care score was linked to a lower risk for incident dementia and stroke in middle-aged and older adults.
The greatest reduction in risk was seen for those receiving 21 to 50 phosphodiesterase type 5 inhibitor prescriptions.
Lower memory levels and faster age-related memory decline also were seen in association with low or very low food security.
The findings persisted across age, sex and comorbidities.
Some of the factors include social isolation, diabetes, heart disease, vitamin D deficiency, high C-reactive protein and low handgrip strength.
Significant reductions were seen in dementia risk for rivaroxaban, apixaban and dabigatran versus warfarin in a network meta-analysis.
The findings were seen among African American individuals, with greater protective effect in APOE ɛ4 noncarriers.
42.2% of clients have dementia in adult day services centers providing specialized care versus 22.7% in nonspecialized centers.
The analysis included occupational trajectories from ages 33 to 65 years.